Advances in basic and clinical immunology in 2008

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

卷:123

Article

Chinen, Javier¹  Shearer, William T.¹ 

[1] Baylor Coll Med, Dept Pediat, Allergy & Immunol Sect, Houston, TX 77030 USA

关键词: Basic immunology;    antigen presentation;    regulatory T cells;    clinical immunology;    primary immunodeficiency;    hereditary angioedema;    hematopoietic stem cell transplantation;    partial DiGeorge syndrome;    HIV infection;   

DOI  :  10.1016/j.jaci.2008.12.1113

来源: Elsevier

【 摘 要 】

We reviewed selected reports in the field of basic and clinical immunology published in 2008. Research progress in the immunologic mechanisms of allergic disease included the modulation of T(H)2 responses by specific transcription factors and receptors associated with the innate immunity, underscoring the importance of the interactions between adaptive and innate immune mechanisms. Investigations of the pathophysiology of hereditary angioedema included a variety of host factors with roles in bradykinin metabolism and vasomotor activity, explaining the variable severity of the clinical presentation. The research focus in HIV infection has shifted from control of disease progression to the barriers for viral eradication, and the search for vaccine designs that provide immunity in the short window between infection and establishment of viral reservoirs. HIV-infected individuals who receive antiviral treatment develop a high incidence of asthma, resembling the inflammatory processes associated with immunoreconstitution. The correlation of molecular diagnosis and clinical presentation was analyzed in 4 relatively rare primary immunodeficiencies: hyper-IgE syndrome; immune dysfunction, polyendocrinopathy, enteropathy, X-linked disease; cartilage-hair hypoplasia; and nuclear factor-kappa B essential modulator deficiency. Studies of patients with partial DiGeorge syndrome and chronic granulomatous disease unveiled subclinical deficiencies that might have an impact in their care. Long-term outcomes from patients with severe combined immunodeficiency who received bone marrow transplants were considered successful compared with the alternative of no intervention. However, the occurrence of adverse events reinforces the need for coordinate efforts to develop optimal protocols for hematopoietic stem cell transplantation for severe immune defects. (J Allergy Clin Immunol 2009;123:328-32.)

【 授权许可】

Free